About Ventripoint Diagnostics Ltd.
Ventripoint has created tools to monitor patients with heart disease, a leading cause of death in developed countries. The VMSTM is the first cost-effective and accurate tool for measuring right ventricle heart function, used for clinical examinations for cardiac indications in Canada, Europe and the United States. Approximately 50% of patients with heart failure have dysfunctional right hearts which go undetected and untreated, leading to repeat hospitalizations. The VMS is designed to reduce healthcare costs while improving quality of life in patients with heart disease. The Company is developing a suite of applications for all major heart diseases and imaging modalities, including congenital heart disease, left or right heart failure and normal hearts – a multi-billion dollar market potential. Learn more about us at